Cite
MLA Citation
Sarah Joseph et al.. “OC 8491 PREPVacc: a phase III, MAMS adaptive prophylactic HIV vaccine trial with a second randomisation to compare F/TAF with TDF/FTC prep.” BMJ global health, vol. 4, n.d., p. A10. http://access.bl.uk/ark:/81055/vdc_100137785113.0x000002